Novel Immunomodulatory Therapies for Respiratory Pathologies
Authors:
- Luciana Pádua TavaresLTLuciana Pádua Tavares
- Izabela GalvãoIGIzabela Galvão
- Maximiliano R FerreroMFMaximiliano R Ferrero
- 1 January 2022
- book chapter
- Published by Elsevier
- p. 554-594
Abstract
No abstract availableKeywords
This publication has 477 references indexed in Scilit:
- CXCR1/CXCR2 Antagonism Is Effective in Pulmonary Defense againstKlebsiella pneumoniaeInfectionBioMed Research International, 2013
- Neutrophil extracellular traps: Is immunity the second function of chromatin?Journal of Cell Biology, 2012
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutationNew England Journal of Medicine, 2011
- Understanding the potential role of statins in pneumonia and sepsis*Critical Care Medicine, 2011
- Cystic fibrosisThe Lancet, 2009
- Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti‐inflammatory eicosanoid, lipoxin A4The FASEB Journal, 2009
- Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airwaysProceedings of the National Academy of Sciences, 2008
- Immunology of asthma and chronic obstructive pulmonary diseaseNature Reviews Immunology, 2008
- Epithelium: At the interface of innate and adaptive immune responsesJournal of Allergy and Clinical Immunology, 2007
- Novel cell death program leads to neutrophil extracellular trapsJournal of Cell Biology, 2007